Klin Farmakol Farm. 2009;23(4):166-170
The aim of this open pilot observation was to prove the influence of the long-term oral systemic enzyme therapy (SE) on subjectively
perceived pain, disabilities caused by back pain and development of late postoperative complications after lumbar disc herniation
surgery.
Patients after lumbar disc herniation surgery (n = 100; aver. age 41,99 year, SD ±9,06) were randomly divided into two groups. All patients
were administered by analgesics and underwent physiotherapy after surgery. The SE group (n = 50, aver. age = 41,24 year, SD ±9,86) was
administered by combined enzyme preparation Phlogenzym (bromelaina 90 mg, trypsinum 48 mg rutosid 100 mg), besides the usual
post-operative treatment. The control group KO (n = 50, aver. age = 42,74 year, SD ±9,39) underwent obligatory treatment only.
Preoperative and postoperative status was evaluated according to Visual Analog Scale (VAS), Roland-Morris questionnaire (RMQ) and
Oswestry Disability Index (ODI). Subjective evaluation of improvement, development of failed back surgery syndrome (FBSS) and ability
to work after surgery were other objectives of the follow-up. Statistical evaluation of the results was accomplished.
Statistically significant differences between individual groups were proved for the benefit of the SE group in subjectively perceived
pain (VAS, p = 0,025), disability for lower back pain (RMQ, p = 0,0006) and in the difference of the patients’ disabilities in common daily
activities (ODI, p = 0,023).
The difference in late postoperative surgery complication occurrence was close to the significance level (p = 0,08). No difference in the
influence of SE therapy on the ability to work (p = 0,68) was found.
This follow-up results are stimulating for continuing research of SE as supportive treatment for patient after lumbar disc herniation surgery.
Published: May 1, 2010 Show citation